Clinical Trial Update: Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on combination chemotherapy as first-line therapy for metastatic pancreatic cancer (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: UNICANCER | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: COMPLETED